Five Questions With: Dr. Stephen Salloway

Dr. Stephen Salloway heads the neurology department and Memory and Aging Program at Butler Hospital, where, as part of a study, some patients have been taking an investigational drug for Alzheimer’s disease since 2013. Biogen, the maker of the drug, halted further research at one point but reversed course and recently announced that it will…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -